This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dong Kook Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ye Ri Lee and Pharmaceutical Formulation Innovation.
Introduction
Ye Ri Lee is an inventor based in Gyeonggi-do, South Korea, associated with Dong Kook Pharm. Co., Ltd. Her listed patent focuses on a pharmaceutical composition combining tadalafil and dutasteride, with specified dissolution characteristics.
Latest Patents
Lee is credited with 1 patent: “Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate.” The composition contains 5 mg of tadalafil and 0.5 mg of dutasteride, or their pharmaceutically acceptable salts. The patent describes dissolution targets for both active ingredients under specified test conditions, addressing how quickly they dissolve in different solutions.
Career Highlights
Lee’s listed invention concerns the formulation and dissolution performance of a combination pharmaceutical product. Her work is associated with Dong Kook Pharm. Co., Ltd.
Collaborations
The provided information lists Jong Sil Kim and Kye Wan Lee as Lee’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Ye Ri Lee’s recorded patent highlights her contribution to pharmaceutical formulation innovation through a tadalafil-and-dutasteride composition with defined dissolution characteristics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile